Jordan Paradise

Loyola University Chicago School of Law

25 E. Pearson

Chicago, IL 60611

United States

SCHOLARLY PAPERS

29

DOWNLOADS
Rank 9,945

SSRN RANKINGS

Top 9,945

in Total Papers Downloads

3,695

CITATIONS
Rank 17,424

SSRN RANKINGS

Top 17,424

in Total Papers Citations

19

Scholarly Papers (29)

1.
Downloads 579 (26,276)

Abstract:

intellectual property law, breast cancer, patent, European Patent Office, opposition, health care, research

2.

Gene Patents: The Need for Bioethics Scrutiny and Legal Change

Yale Journal of Health, Policy, Law and Ethics, Vol. 5, 2005
Number of pages: 10 Posted: 24 Apr 2006
Jordan Paradise and Lori Andrews
Loyola University Chicago School of Law and Chicago-Kent College of Law
Downloads 319 (72,507)

Abstract:

gene patent, health care, research

3.

No Sisyphean Task: How the FDA Can Regulate Electronic Cigarettes

XIII Yale Journal of Health Policy, Law, and Ethics 1-32 (Spring 2013).
Number of pages: 32 Posted: 28 Jul 2012 Last Revised: 17 Jul 2013
Jordan Paradise
Loyola University Chicago School of Law
Downloads 301 (74,026)

Abstract:

electronic cigarettes, FDA, Family Smoking Prevention and Tobacco Control Act, marketing, promotion, safety

4.

Exploring Emerging Nanobiotechnology Drugs and Medical Devices

Food & Drug Law Journal, Vol. 63, No. 2, pp. 407-420, 2008
Number of pages: 15 Posted: 05 Jun 2008
Loyola University Chicago School of Law, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota - Twin Cities - Dept of Sociology and University of Minnesota, Twin Cities
Downloads 170 (133,799)
Citation 3

Abstract:

nanotechnology, FDA, drugs, medical devices, combination products, regulation

5.

The Devil is in the Details: Health Care Reform, Biosimilars, and Implementation Challenges for the Food and Drug Administration

Jurimetrics Journal, Vol. 51, pp. 279–292, 2011,
Number of pages: 14 Posted: 26 May 2011 Last Revised: 28 Jul 2013
Jordan Paradise
Loyola University Chicago School of Law
Downloads 131 (170,095)

Abstract:

Biologics, Food and Drug Administration, biosimilars, Patient Protection and Affordable Care Act

6.

Lessons from the European Union: The Need for a Post-Grant Mechanism for Third-Party Challenge to U.S. Patents

Minnesota Journal of Law, Science & Technology, Vol. 7, No. 1, pp. 315-326, 2005, Minnesota Legal Studies Research Paper No. 06-22
Number of pages: 12 Posted: 27 Apr 2006
Jordan Paradise
Loyola University Chicago School of Law
Downloads 131 (169,109)

Abstract:

BRCA, patents, genetics research, health care, European Union, opposition

7.

Developing Oversight Frameworks for Nanobiotechnology

Minnesota Journal of Law, Science & Technology, Vol. 9, No. 1, pp. 187-203, 2008
Number of pages: 17 Posted: 09 Mar 2008 Last Revised: 18 Nov 2014
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities - School of Law and University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs
Downloads 129 (173,158)
Citation 1

Abstract:

nanotechnology, regulation, oversight, federal agencies

8.

Recommendations for Oversight of Nanobiotechnology: Dynamic Oversight for Complex and Convergent Technology

Journal of Nanoparticle Research, Vol. 13, pp. 1345-1371, 2011
Number of pages: 47 Posted: 23 Jan 2011 Last Revised: 28 Jul 2013
University of Minnesota, Twin Cities, University of Minnesota Law School, Loyola University Chicago School of Law, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota, Twin Cities - School of Law, University of Minnesota, Twin Cities and University of Minnesota - Twin Cities - Hubert H. Humphrey Institute of Public Affairs
Downloads 118 (178,476)
Citation 1

Abstract:

Science Oversight, Technology Oversight, Dynamic Oversight, New Governance, Science Regulation, Technology Regulation, Nanotechnology, Nanobiotechnology, NNI, FDA, EPA, OSHA, NIOSH, NIH, OSTP, Law and Science, Bioethics

9.

Synthetic Biology: Does Re-Writing Nature Require Re-Writing Regulation?

117 Penn St. L. Rev. 53 (2012).
Number of pages: 36 Posted: 20 Dec 2011 Last Revised: 18 Apr 2013
Jordan Paradise and Ethan Fitzpatrick
Loyola University Chicago School of Law and Seton Hall University - School of Law
Downloads 108 (192,379)

Abstract:

synthetic biology, FDA, safety, medical products

10.

Genetic Sequence Patents: Historical Justification and Current Impacts

Max Planck Conference, Living Properties: Making Knowledge and Controlling Ownership in the History of Biology, pp. 137-164, 2009
Number of pages: 46 Posted: 30 Jun 2010
Lori Andrews and Jordan Paradise
Chicago-Kent College of Law and Loyola University Chicago School of Law
Downloads 100 (196,118)

Abstract:

gene patents, products of nature, process, USPTO, case law

11.

The Legal and Regulatory Status of Biosimilars: How Product Naming and State Substitution Laws May Impact the U.S. Healthcare System

41 American Journal of Law and Medicine 49 (2015).
Number of pages: 36 Posted: 27 Jan 2015 Last Revised: 28 Jul 2016
Jordan Paradise
Loyola University Chicago School of Law
Downloads 99 (158,876)

Abstract:

biosimilars, biologics, FDA, naming, substitution, health care, Biologics Price Competition and Innovation Act, Affordable Care Act

12.

Follow-On Biologics: Implementation Challenges and Opportunities

Seton Hall Law Review, Vol. 41, p. 501, 2011
Number of pages: 10 Posted: 26 May 2011
Jordan Paradise
Loyola University Chicago School of Law
Downloads 95 (202,681)

Abstract:

Biologics, FDA, Biologics Price Competition and Affordable Care Act

13.

Reassessing Safety for Nanotechnology Combination Products: What Do 'Biosimilars' Add to Regulatory Challenges for the FDA?

Jordan Paradise, Reassessing Safety for Nanotechnology Combination Products: What Do Biosimilars Add to Regulatory Challenges for the FDA?, 56 St. Louis U. L. J. 465 (2012)., Saint Louis U. Legal Studies Research Paper
Number of pages: 56 Posted: 29 May 2011 Last Revised: 09 Jan 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 83 (216,930)

Abstract:

nanotechnology, Food and Drug Administration, drugs, devices, biologics, health care reform

14.

Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations

Journal of Law, Medicine and Ethics, Vol. 36, No. 2, pp. 219-248, 2008
Number of pages: 30 Posted: 08 Dec 2010 Last Revised: 06 Feb 2014
University of Minnesota Law School, University of Minnesota - Twin Cities, Harvard Medical School, Johns Hopkins Berman Institute of Bioethics, Stanford University - Stanford Center for Biomedical Ethics (SCBE), Vanderbilt University - Law School, Mayo Clinic - College of Medicine, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities, National Institutes of Health (NIH), University of British Columbia (UBC), Pennsylvania State University, University of Minnesota - Twin Cities, University of California, San Francisco (UCSF), University of Minnesota - Twin Cities, St. Luke's Hospital, Loyola University Chicago School of Law, University of Pittsburgh, Genetic Alliance, University of Minnesota - Twin Cities and University of Washington
Downloads 83 (211,131)
Citation 5

Abstract:

incidental findings, human subjects research, bioethics, health law

15.

Tales from the Crypt: Scientific, Ethical, and Legal Considerations for Biohistorical Analysis of Deceased Historical Figures

Temple Journal of Science, Technology & Environmental Law, Vol. 26, pp. 223-299, 2007
Number of pages: 77 Posted: 10 Jan 2008
Jordan Paradise and Lori Andrews
Loyola University Chicago School of Law and Chicago-Kent College of Law
Downloads 80 (212,500)

Abstract:

genetics research, biohistory, historical figures

The Challenge of Developing Oversight Approaches to Nanobiotechnology

Journal of Law, Medicine & Ethics, Vol. 37, pp. 543-545, 2009
Number of pages: 3 Posted: 01 Jul 2010 Last Revised: 27 Apr 2012
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota, Twin Cities and University of Minnesota, Twin Cities
Downloads 47 (329,836)
Citation 2

Abstract:

nanotechnology, nanobiotechnology, United States, oversight, law

The Challenge of Developing Oversight Approaches to Nanobiotechnology

Journal of Law, Medicine and Ethics, Vol. 37, No. 4, p. 535, Winter 2009
Number of pages: 8 Posted: 06 Jan 2011
University of Minnesota Law School, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs and Loyola University Chicago School of Law
Downloads 31 (387,259)
Citation 2

Abstract:

nanotechnology, nanobiotechnology, law and science, technology oversight, science oversight, regulation of science and technology, emerging technologies, law and empirical studies. FDA, EPA, OSHA, NIOSH, NIH, RAC, USDA, NNI

17.

Claiming Nanotechnology: Improving USPTO Efforts at Classification of Emerging Nano-Enabled Pharmaceutical Technologies

Northwestern Journal of Technology and Intellectual Property, Vol. 10, No. 3, pp. 169-207, 2012
Number of pages: 42 Posted: 27 Oct 2011 Last Revised: 22 Feb 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 77 (237,822)

Abstract:

USPTO, nanotechnology, patents, pharmaceuticals, drugs, claims, classification, science and law, technology and law, intellectual property law, federal agencies

18.

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences

Journal of Law, Medicine & Ethics, Vol. 37, No. 4, pp. 688-705, Winter 2009
Number of pages: 18 Posted: 30 Jun 2010 Last Revised: 18 Nov 2014
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota, Twin Cities and University of Minnesota, Twin Cities
Downloads 77 (245,069)
Citation 2

Abstract:

19.

REMS as a Competitive Tactic: Is Big Pharma Hijacking Drug Access and Patient Safety?

15 Houston Journal of Health Law and Policy 43 (2015).
Number of pages: 40 Posted: 27 Jan 2015 Last Revised: 23 Oct 2015
Jordan Paradise
Loyola University Chicago School of Law
Downloads 71 (172,097)

Abstract:

FDA, risk evaluation and mitigation strategies, REMS, anticompetitive, labeling, postmarket, generic drugs, drug approval

20.

The Law of Incidental Findings in Human Subjects Research: Establishing Researchers' Duties

Journal of Law, Medicine & Ethics, Vol. 36, No. 2, pp. 361-383, 2008
Number of pages: 23 Posted: 30 Jun 2010 Last Revised: 25 Dec 2010
Susan M. Wolf, Jordan Paradise and Charlisse Caga Anan
University of Minnesota Law School, Loyola University Chicago School of Law and Cleveland Clinic Foundation - Department of Bioethics
Downloads 67 (262,622)
Citation 1

Abstract:

incidental findings, genetics, research, informed consent, disclosure of results, law, ethics

21.

Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology

Journal of Law, Medicine & Ethics, Vol. 37, No. 4, pp. 598-624, Winter 2009
Number of pages: 27 Posted: 30 Jun 2010
Loyola University Chicago School of Law, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota, Twin Cities - School of Law and University of Minnesota, Twin Cities
Downloads 53 (291,809)
Citation 1

Abstract:

Food and Drug Administration, nanotechnology, nanobiotechnology, drugs, medical devices, oversight

22.

Nanobiotechnology and the Food and Drug Administration

Food and Drug Law Institute Update, pp. 23-35, March/April 2010
Number of pages: 3 Posted: 30 Jun 2010
Jordan Paradise
Loyola University Chicago School of Law
Downloads 52 (304,609)

Abstract:

23.

An Integrated Approach to Oversight Assessment for Emerging Technologies

Risk Analysis, Vol. 28, No. 5, pp. 1197-1219, 2008
Number of pages: 23 Posted: 16 Jan 2011 Last Revised: 22 Jan 2011
University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, Loyola University Chicago School of Law, University of Minnesota, Twin Cities, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities and University of Minnesota Law School
Downloads 43 (333,084)
Citation 3

Abstract:

Nanotechnology, nanobiotechnology, science and technology, emerging technology, oversight, oversight systems, empirical studies, expert elicitation, multi-criteria assessment, risk analysis, science regulation, oversight assessment, new governance, gene therapy, biotechnology, GMOs

24.

Patents on Human Genes: An Analysis of Scope and Claims

Science, Vol. 307, 2005
Number of pages: 2 Posted: 24 Apr 2006 Last Revised: 18 Jun 2013
Jordan Paradise, Lori Andrews and Timothy R. Holbrook
Loyola University Chicago School of Law, Chicago-Kent College of Law and Emory University School of Law
Downloads 34 (258,515)

Abstract:

United States Patent & Trademark Office, patent, claim, gene

25.

Cultivating Innovation in Precision Medicine Through Regulatory Flexibility at the FDA

Posted: 14 Feb 2017
Jordan Paradise
Loyola University Chicago School of Law

Abstract:

Precision medicine, companion diagnostics, drugs, medical devices, FDA, regulation, 21st Century Cures Act, innovation

26.

A Profile of Bio-Pharma Consolidation Activity

Annals of Health Law, Vol. 25, No. 2, 2016
Number of pages: 28 Posted: 29 Jul 2016 Last Revised: 02 Sep 2016
Jordan Paradise
Loyola University Chicago School of Law
Downloads 0 (307,254)

Abstract:

pharmaceuticals, generic drugs, prescription drugs, mergers, consolidation, Federal Trade Commission, drug prices, antitrust

27.

U.S. Regulatory Challenges for Gene Editing

Number of pages: 8 Posted: 29 Jul 2016
Jordan Paradise
Loyola University Chicago School of Law
Downloads 0 (231,150)

Abstract:

Gene editing, regulation, FDA

28.

Patient Advocacy Group Collaboration in Genetic Research and The Scope of 'Joint Inventorship' Under U.S. Patent Law

International Journal of Intellectual Property Management, Vol. 3, No. 2, pp. 97-109, 2009
Posted: 28 Jul 2009 Last Revised: 18 Jun 2013
Jordan Paradise
Loyola University Chicago School of Law

Abstract:

29.

Decoding the Research Exemption

Nature Reviews Genetics, Vol. 7, No. 2, pp. 148-154, 2006
Posted: 25 May 2006 Last Revised: 14 Nov 2012
Jordan Paradise and Christopher Janson
Loyola University Chicago School of Law and NEAR

Abstract:

genetics, research, patents, research exemption, international

Other Papers (5)

Total Downloads: 33    Citations: 0
1.

States Tackle Biosimilar Substitution

Health Reform Watch, March 2014
Number of pages: 3 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 11

Abstract:

FDA, biosimilar, interchangeable, state laws, substitution

2.

Funding, and Ethics, for the BRAIN Initiative

Health Reform Watch, October 2013
Number of pages: 2 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 3

Abstract:

BRAIN initiative, bioethics, federal funding, neuroscience, law

3.

The Trans Fat Smackdown

Health Reform Watch, November 2013
Number of pages: 2 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 3

Abstract:

FDA, trans fat, regulations

4.

FDA's Proposed Changes to Generic Drug Label Rules Questioned by Members of Congress

Health Reform Watch, January 2014
Number of pages: 2 Posted: 03 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 2

Abstract:

generic drugs, labeling, proposed regulation, FDA, Supreme Court

5.

FDA Taking Baby Steps Toward Regulating Nanotechnology

Health Reform Watch, June 2011
Number of pages: 4 Posted: 04 Apr 2014
Jordan Paradise
Loyola University Chicago School of Law
Downloads 1

Abstract:

FDA, nanotechnology, drug, biologic, device